Anxiety Disorders & Depression Treatment Market To Reach $19.28 Billion By 2030

Anxiety Disorders And Depression Treatment Market Growth & Trends

The global anxiety disorders and depression treatment market size is estimated to reach USD 19.28 billion by 2030, registering to grow at a CAGR of 3.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in recent years.

The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.

 Request a free sample copy or view report summary: Anxiety Disorders And Depression Treatment Market Report

Anxiety Disorders And Depression Treatment Market Report Highlights

• The antidepressants segment dominated the market and accounted for the highest revenue share of 32.4% in 2024. 

• Anxiety led the market with a revenue share of 55.4% in 2024, fueled by the increased presence of phobias, social anxiety disorders, and other similar conditions in both established and growing economies. 

• The retail pharmacies segment held the largest market share of 55.4% in 2024 due to patients’ preference for nearby, trustworthy pharmacies. 

• North America anxiety disorders and depression treatment market dominated the global market with a revenue share of 37.6% in 2024.

Anxiety Disorders And Depression Treatment Market Segmentation

Grand View Research has segmented the global anxiety disorders and depression treatment market based on drug type, indication, distribution channel, and region:

Anxiety Disorders And Depression Treatment Drug Type Outlook (Revenue, USD Million, 2018 - 2030)

• Antidepressants

• Anxiolytics

• Anticonvulsants

• Noradrenergic Agents

• Atypical Antipsychotics

Anxiety Disorders And Depression Treatment Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Depression

• Anxiety

Anxiety Disorders And Depression Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies

• Retail Pharmacies

• Others

Anxiety Disorders And Depression Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Anxiety Disorders And Depression Treatment Market

• Pfizer Inc.

• H. Lundbeck A/S

• GSK plc

• Merck & Co., Inc.

• Eli Lilly and Company

• AstraZeneca

• Bristol-Myers Squibb Company

• Johnson & Johnson Services, Inc.

• AbbVie Inc.

• Sanofi